Planview-bloggen

Din väg till smidighet i affärsverksamheten

Förvaltning av produktportföljen, Förvaltning av projektportföljer, Strategisk planering

Upcoming Conferences on PPM and Innovation – Enrich Consulting

Publicerad By Dr. Richard Sonnenblick

Fall and winter is high season for conferences, and we’re excited to be sponsoring five different events across North America and Europe between now and March 2016. We recommend all of these conferences as excellent opportunities to network, learn from your peers, and share your own wisdom on innovation and portfolio management.

Boston, October 6-7: 8th Project and Portfolio Management for Pharma & Biotech Conference at the Hyatt Regency Boston. Organized by American Leaders. We sponsored their spring conference in San Francisco and found the conference not too big, not too small, and full of industry veterans doing great work at small- and mid-sized firms.

Amsterdam, October 12-13: Product Innovation Process 2016. This is our first experience with this cross-industry event, focusing on portfolio management and other methods that create R&D value.

Philadelphia, November 2-3: Cambridge Healthtech’s Strategic Resource and Portfolio Management Conference at the Hilton Philadelphia, Penn’s Landing. This is the biggest life sciences event we attend in North America. Usually there are 150-200 attendees at these back-to-back events, with a majority attending both of them. When you bring the resource planning and portfolio people together at one venue, good conversations ensue.

NYC, January 20-21, 2016: EBCG’s Pharma PPM Toolbox North America, This is EBCG’s first version of this conference in the US, in the middle of Manhattan. We’re excited to be part of the inaugural event.

Basel, March 3-4, 2016: EBCG’s Pharma PPM Toolbox Europe, Our new favorite conference in Europe. Basel is a great venue, and EBCG brings together 150+ delegates from leading life sciences companies all over Europe.

Relaterade inlägg

Skrivet av Dr. Richard Sonnenblick Chief Data Scientist

Sonnenblick, Planviews Chief Data Scientist, har många års erfarenhet av att arbeta med några av världens största läkemedels- och life science-företag. Genom denna djupgående studie och tillämpning har han framgångsrikt formulerat insiktsfulla prioriterings- och portföljgranskningsprocesser, poängsystem samt finansiella värderings- och prognosmetoder för att förbättra både produktprognoser och portföljanalys. Sonnenblick har en Ph.D. och MS från Carnegie Mellon University i teknik och offentlig politik och en BA i fysik från University of California, Santa Cruz.